TÜV NORD has announced the acquisition of RISE MNB, a Swedish medical device certification body, to strengthen its capabilities and market presence in Europe.
Information on the Target
RISE MNB, a wholly-owned subsidiary of RISE, operates as a notified body for medical devices in accordance with the Medical Device Regulation (MDR) 2017/745. It is accredited for certification under ISO 13485 and conducts evaluations of various medical device categories, including software, measurement products, assistive devices, dental products, and sterile products. RISE MNB's mission is to facilitate access to the entire EU market for its clients, thereby enhancing the competitiveness and renewal of Swedish industry.
Established in 2022, RISE MNB has significantly contributed to the Swedish healthcare sector by providing the necessary certifications and guidance for medical products to meet regulatory standards. As the company reaches the conclusion of its initial objectives, the acquisition by TÜV NORD is considered a strategic move to ensure long-term growth and development of the services offered to clients, as stated by Malin Frenning, CEO of RISE.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in Sweden
The healthcare and medical technology sector in Sweden is known for its innovative approaches and high standards in product development. With a strong emphasis on research and development, Sweden ranks among the top countries in Europ
Similar Deals
ANTCO. Investment Group AB (publ) → Deversify AB
2025
ANTCO. Investment Group AB (publ) → Dynamic Code AB (publ)
2025
TÜV NORD
invested in
RISE MNB
in 2026
in a Other deal